{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:21:29Z","timestamp":1789125689072,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41409-026-02957-3","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:42:09Z","timestamp":1782578529000},"page":"1188-1195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fludarabine, cyclophosphamide and 2\u2009Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patients"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8810-7117","authenticated-orcid":false,"given":"Guillaume","family":"Berton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7185-6994","authenticated-orcid":false,"given":"Sabine","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-2595","authenticated-orcid":false,"given":"Benjamin","family":"Bouchacourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Nykolyszyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandre","family":"Petit-Deharo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Srour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0541-6320","authenticated-orcid":false,"given":"Ilaria","family":"Pili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Demerl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1684-6030","authenticated-orcid":false,"given":"Boris","family":"Calmels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Lemari\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Line","family":"Ch\u00e2teau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Anne","family":"Hospital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Garciaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-4889","authenticated-orcid":false,"given":"Christian","family":"Chabannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8120-7781","authenticated-orcid":false,"given":"Pierre-Jean","family":"Weiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-9447","authenticated-orcid":false,"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-8310","authenticated-orcid":false,"given":"Raynier","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"2957_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"2957_CR2","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.bbmt.2020.06.007","volume":"26","author":"MCB Bittencourt","year":"2020","unstructured":"Bittencourt MCB, Ciurea SO. Recent advances in allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Biol Blood Marrow Transpl. 2020;26:e215\u201321.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/stcltm\/szac015","volume":"11","author":"S Servais","year":"2022","unstructured":"Servais S, Beguin Y, Baron F. Current status and perspectives of allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia. Stem Cells Transl Med. 2022;11:461\u201377.","journal-title":"Stem Cells Transl Med"},{"key":"2957_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41409-022-01674-x","volume":"57","author":"R Devillier","year":"2022","unstructured":"Devillier R, Galimard JE, Labopin M, Blaise D, Raiola AM, Pavlu J, et al. Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. Bone Marrow Transpl. 2022;57:1421\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"2957_CR5","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.bbmt.2018.02.002","volume":"24","author":"R Devillier","year":"2018","unstructured":"Devillier R, Legrand F, Rey J, Castagna L, F\u00fcrst S, Granata A, et al. HLA-matched sibling versus unrelated versus haploidentical related donor allogeneic hematopoietic stem cell transplantation for patients aged over 60 years with acute myeloid leukemia: a single-center donor comparison. Biol Blood Marrow Transpl. 2018;24:1449\u201354.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","volume":"39","author":"L Luznik","year":"2012","unstructured":"Luznik L, O\u2019Donnell PV, Fuchs EJ. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol. 2012;39:683\u201393.","journal-title":"Semin Oncol"},{"key":"2957_CR8","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1182\/blood-2015-01-623991","volume":"125","author":"SR McCurdy","year":"2015","unstructured":"McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bola\u00f1os-Meade J, Rosner GL, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 2015;125:3024\u201331.","journal-title":"Blood"},{"key":"2957_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41409-023-02134-w","volume":"59","author":"S Harbi","year":"2024","unstructured":"Harbi S, Brac De La Perriere L, Bouchacourt B, Garciaz S, Pagliardini T, Calmels B, et al. Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome. Bone Marrow Transpl. 2024;59:101\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"2957_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41409-019-0682-2","volume":"55","author":"C Nykolyszyn","year":"2020","unstructured":"Nykolyszyn C, Granata A, Pagliardini T, Castagna L, Harbi S, Bouabdallah R, et al. Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation. Bone Marrow Transpl. 2020;55:349\u201355. f\u00e9vr.","journal-title":"Bone Marrow Transpl"},{"key":"2957_CR11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41409-023-02033-0","volume":"58","author":"F Dachy","year":"2023","unstructured":"Dachy F, Furst S, Calmels B, Pagliardini T, Harbi S, Bouchacourt B, et al. GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10\/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2023;58:1179\u201381.","journal-title":"Bone Marrow Transpl"},{"key":"2957_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41409-022-01908-y","volume":"58","author":"R Dul\u00e9ry","year":"2023","unstructured":"Dul\u00e9ry R, Goudet C, Mannina D, Bianchessi A, Granata A, Harbi S, et al. Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies. Bone Marrow Transpl. 2023;58:386\u201392.","journal-title":"Bone Marrow Transpl"},{"key":"2957_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bjh.15544","volume":"185","author":"R Cauchois","year":"2019","unstructured":"Cauchois R, Castagna L, Pagliardini T, Harbi S, Calmels B, Bramanti S, et al. Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells. Br J Haematol. 2019;185:570\u20133.","journal-title":"Br J Haematol"},{"key":"2957_CR14","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.bulcan.2018.10.002","volume":"106","author":"J De Vos","year":"2019","unstructured":"De Vos J, Baudoux E, Bay JO, Calmels B, Cras A, El Cheikh J, et al. Injections de lymphocytes du donneur (DLI): recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC). Bull Cancer (Paris). 2019;106:S35\u20139.","journal-title":"Bull Cancer (Paris)"},{"key":"2957_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","volume":"59","author":"A Sureda","year":"2024","unstructured":"Sureda A, Carpenter PA, Bacigalupo A, Bhatt VR, De La Fuente J, Ho A, et al. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT. Bone Marrow Transpl. 2024;59:832\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"2957_CR16","doi-asserted-by":"publisher","unstructured":"Zeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Ad\u00e8s L, Borate U, et al. Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes. Blood. 1 f\u00e9vr 2023;blood.2022018604. https:\/\/doi.org\/10.1182\/blood.2022018604","DOI":"10.1182\/blood.2022018604"},{"key":"2957_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transpl. 2016;22:4\u201310.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR18","doi-asserted-by":"crossref","unstructured":"on behalf of the EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the \u201cEBMT\u2212NIH (National Institutes of Health)\u2212CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force\u201d, Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, et al. EBMT\u2212NIH\u2212CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53:1401\u201315.","DOI":"10.1038\/s41409-018-0204-7"},{"key":"2957_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2307\/2530374","volume":"34","author":"RL Prentice","year":"1978","unstructured":"Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541\u201354.","journal-title":"Biometrics"},{"key":"2957_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"2957_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"2957_CR22","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912\u20139.","journal-title":"Blood"},{"key":"2957_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2014.113571","volume":"100","author":"D Blaise","year":"2015","unstructured":"Blaise D, Devillier R, Lecoroller-Sorriano AG, Boher JM, Boyer-Chammard A, Tabrizi R, et al. Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial. Haematologica. 2015;100:269\u201374.","journal-title":"Haematologica"},{"key":"2957_CR24","first-page":"794","volume":"30","author":"LM Morsink","year":"2024","unstructured":"Morsink LM, Hazenberg CLE, Choi G, De Groot MR, Biswana A, Bellido M, et al. Improved outcome of allogeneic transplantation in older patients treated for myeloid malignancies using post-transplantation cyclophosphamide and reduced duration of immune suppression. Transpl Cell Ther. 2024;30:794\u2013807.","journal-title":"Transpl Cell Ther"},{"key":"2957_CR25","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1182\/bloodadvances.2020001620","volume":"4","author":"J Mariotti","year":"2020","unstructured":"Mariotti J, Raiola AM, Evangelista A, Carella AM, Martino M, Patriarca F, et al. Impact of donor age and kinship on clinical outcomes after T-cell\u2013replete haploidentical transplantation with PT-Cy. Blood Adv. 2020;4:3900\u201312.","journal-title":"Blood Adv"},{"key":"2957_CR26","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbmt.2017.09.005","volume":"24","author":"SO Ciurea","year":"2018","unstructured":"Ciurea SO, Shah MV, Saliba RM, Gaballa S, Kongtim P, Rondon G, et al. Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transpl. 2018;24:1232\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ajh.24963","volume":"93","author":"J Canaani","year":"2018","unstructured":"Canaani J, Savani BN, Labopin M, Huang X, Ciceri F, Arcese W, et al. Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. Am J Hematol. 2018;93:246\u201353.","journal-title":"Am J Hematol"},{"key":"2957_CR28","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","volume":"98","author":"C Kollman","year":"2001","unstructured":"Kollman C, Howe CWS, Anasetti C, Antin JH, Davies SM, Filipovich AH, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043\u201351.","journal-title":"Blood"},{"key":"2957_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1326","volume":"11","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med. 2005;11:1299\u2013305.","journal-title":"Nat Med"},{"key":"2957_CR30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1189\/jlb.0907627","volume":"84","author":"R Simone","year":"2008","unstructured":"Simone R, Zicca A, Saverino D. The frequency of regulatory CD3+CD8+CD28\u2212CD25+ T lymphocytes in human peripheral blood increases with age. J Leukoc Biol. 2008;84:1454\u201361.","journal-title":"J Leukoc Biol"},{"key":"2957_CR31","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI124218","volume":"129","author":"LP Wachsmuth","year":"2019","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019;129:2357\u201373.","journal-title":"J Clin Invest"},{"key":"2957_CR32","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1182\/bloodadvances.2024014858","volume":"9","author":"K Nath","year":"2025","unstructured":"Nath K, Zhang MJ, Bye M, Abid MB, Benjamin C, Betts B, et al. Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis. Blood Adv. 2025;9:3469\u201378.","journal-title":"Blood Adv"},{"key":"2957_CR33","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.bbmt.2019.05.037","volume":"25","author":"O Ringd\u00e9n","year":"2019","unstructured":"Ringd\u00e9n O, Boumendil A, Labopin M, Canaani J, Beelen D, Ehninger G, et al. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2019;25:1975\u201383.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbmt.2016.09.027","volume":"23","author":"S Heidenreich","year":"2017","unstructured":"Heidenreich S, Ziagkos D, De Wreede LC, Van Biezen A, Finke J, Platzbecker U, et al. Allogeneic stem cell transplantation for patients age \u2265 70 years with myelodysplastic syndrome: a retrospective study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. Biol Blood Marrow Transpl. 2017;23:44\u201352.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR35","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","volume":"33","author":"YL Kasamon","year":"2015","unstructured":"Kasamon YL, Bola\u00f1os-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, et al. Outcomes of nonmyeloablative hla-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol. 2015;33:3152\u201361.","journal-title":"J Clin Oncol"},{"key":"2957_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","volume":"126","author":"SO Ciurea","year":"2015","unstructured":"Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. Blood. 2015;126:1033\u201340.","journal-title":"Blood"},{"key":"2957_CR37","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1182\/bloodadvances.2019000155","volume":"3","author":"PH Imus","year":"2019","unstructured":"Imus PH, Tsai HL, Luznik L, Fuchs EJ, Huff CA, Gladstone DE, et al. Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70. Blood Adv. 2019;3:2608\u201316.","journal-title":"Blood Adv"},{"key":"2957_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/bjh.13923","volume":"176","author":"R Devillier","year":"2017","unstructured":"Devillier R, Granata A, F\u00fcrst S, Harbi S, Faucher C, Weiller P, et al. Low incidence of chronic GVHD after HLA -haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients. Br J Haematol. 2017;176:132\u20135. janv.","journal-title":"Br J Haematol"},{"key":"2957_CR39","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/ajh.27343","volume":"99","author":"R Devillier","year":"2024","unstructured":"Devillier R, Galimard J, Blaise D, Raiola AM, Bramanti S, Grillo G, et al. Peripheral blood stem cell versus bone marrow graft for patients \u226560 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Am J Hematol. 2024;99:1250\u20136.","journal-title":"Am J Hematol"},{"key":"2957_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1182\/blood-2011-07-367508","volume":"119","author":"S Kayser","year":"2012","unstructured":"Kayser S, Zucknick M, D\u00f6hner K, Krauter J, K\u00f6hne CH, Horst HA, et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood. 2012;119:551\u20138.","journal-title":"Blood"},{"key":"2957_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/ejh.12216","volume":"92","author":"PG Hemmati","year":"2014","unstructured":"Hemmati PG, Schulze-Luckow A, Terwey TH, Le Coutre P, Vuong LG, D\u00f6rken B, et al. Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission. Eur J Haematol. 2014;92:102\u201310.","journal-title":"Eur J Haematol"},{"key":"2957_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/ejh.13434","volume":"105","author":"Y Choi","year":"2020","unstructured":"Choi Y, Lee J, Lee J, Park H, Choi E, Jo J, et al. Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission. Eur J Haematol. 2020;105:262\u201373.","journal-title":"Eur J Haematol"},{"key":"2957_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbmt.2010.05.012","volume":"17","author":"B Oran","year":"2011","unstructured":"Oran B, Dolan M, Cao Q, Brunstein C, Warlick E, Weisdorf D. Monosomal Karyotype Provides Better Prognostic Prediction after Allogeneic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia. Biol Blood Marrow Transpl. 2011;17:356\u201364.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2957_CR44","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1182\/bloodadvances.2019000797","volume":"4","author":"J Zou","year":"2020","unstructured":"Zou J, Ciurea SO, Kongtim P, Yi M, Carmazzi Y, Rondon G, et al. Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation. Blood Adv. 2020;4:3474\u201385.","journal-title":"Blood Adv"},{"key":"2957_CR45","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1182\/bloodadvances.2020003110","volume":"4","author":"SR Solomon","year":"2020","unstructured":"Solomon SR, Aubrey MT, Zhang X, Jackson KC, Morris LE, Holland HK, et al. Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide. Blood Adv. 2020;4:5311\u201321.","journal-title":"Blood Adv"},{"key":"2957_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101093","volume":"62","author":"SR McCurdy","year":"2023","unstructured":"McCurdy SR, Luznik L. Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight. Blood Rev. 2023;62:101093.","journal-title":"Blood Rev"},{"key":"2957_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01072-0","volume":"14","author":"Y Ye","year":"2024","unstructured":"Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T, Blaise D, et al. Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood Cancer J. 2024;14:85.","journal-title":"Blood Cancer J"},{"key":"2957_CR48","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1182\/blood-2025-1059","volume":"146","author":"Y Ye","year":"2025","unstructured":"Ye Y, Galimard JE, Labopin M, Ayuk F, Yakoub-Agha I, Stelljes M, et al. Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT. Blood. 2025;146:1059\u20131059.","journal-title":"Blood"},{"key":"2957_CR49","first-page":"973","volume":"31","author":"AM Jimenez Jimenez","year":"2025","unstructured":"Jimenez Jimenez AM, Spellman SR, Politikos I, McCurdy SR, Devine SM, Malki MMA, et al. Allogeneic hematopoietic cell donor selection: contemporary guidelines from the NMDP\/CIBMTR. Transpl Cell Ther. 2025;31:973\u201388.","journal-title":"Transpl Cell Ther"},{"key":"2957_CR50","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1182\/blood.2023023697","volume":"143","author":"J Sanz","year":"2024","unstructured":"Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, et al. Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT. Blood. 2024;143:2534\u201343.","journal-title":"Blood"},{"key":"2957_CR51","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1200\/JCO.24.00184","volume":"42","author":"BC Shaffer","year":"2024","unstructured":"Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bola\u00f1os-Meade J, Abboud R, et al. Post-transplant cyclophosphamide\u2013based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors. J Clin Oncol. 2024;42:3277\u201386.","journal-title":"J Clin Oncol"},{"key":"2957_CR52","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1200\/JCO.24.00582","volume":"42","author":"E Arrieta-Bola\u00f1os","year":"2024","unstructured":"Arrieta-Bola\u00f1os E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, et al. Human leukocyte antigen mismatching and survival in contemporary hematopoietic cell transplantation for hematologic malignancies. J Clin Oncol. 2024;42:3287\u201399.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02957-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:04:02Z","timestamp":1789124642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02957-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2957"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02957-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}